Successfully navigating the FDA approval process is a vital component of any regulated company's business plan.  This Biotech Forum will provide practical and timely insight on how to work with FDA from a panel of industry experts.  The focus is on providing information that is useful to companies that are dealing with FDA.  The speakers will share tips and strategies on whether you are evaluating the possible pathways to approval, charting a clinical study program, or preparing to meet with FDA to discuss a proposed project.

Speakers

• Mark A. Baumgartner, Senior Director, Global Regulatory Affairs, GlaxoSmithKline